Toll-Like Receptors Expression and Signaling in Glia Cells in Neuro-Amyloidogenic Diseases: Towards Future Therapeutic Application

Toll-like receptors (TLRs) are known to be expressed by innate immune response cells and to play a critical role in their activation against foreign pathogens. It was recently suggested that TLRs have an important role in the crosstalk between neurons and glial cells in the central nervous system (CNS). TLR signaling was reported to be associated with a yin-yang effect in the CNS. While TLR signaling was linked to neurogenesis, it was also found to be involved in the pathogenesis of neurodegenerative diseases. This paper will focus on TLR signaling in glial cells in neurodegenerative diseases such as Alzheimer's disease, prion diseases, amyotrophic lateral sclerosis, and Parkinson's disease. Understanding the pattern of TLR signaling in the glial cells may lead to the identification of new targets for therapeutic application.

[1]  H. Aldskogius Microglia in neuroregeneration , 2001, Microscopy research and technique.

[2]  S. Akira,et al.  The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 , 2001, Nature.

[3]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[4]  H. Neumann,et al.  LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. , 2005, Brain : a journal of neurology.

[5]  Hiroki Toda,et al.  Inflammatory Blockade Restores Adult Hippocampal Neurogenesis , 2003, Science.

[6]  Holger Heine,et al.  Role of the Toll-Like Receptor 4 in Neuroinflammation in Alzheimer’s Disease , 2007, Cellular Physiology and Biochemistry.

[7]  C. Brosnan,et al.  Astrocyte Indoleamine 2,3-Dioxygenase Is Induced by the TLR3 Ligand Poly(I:C): Mechanism of Induction and Role in Antiviral Response , 2007, Journal of Virology.

[8]  R. Ravid,et al.  Broad Expression of Toll‐Like Receptors in the Human Central Nervous System , 2002, Journal of neuropathology and experimental neurology.

[9]  S. Fahn,et al.  Parkinson's disease: Neurodegenerative mechanisms and neuroprotective interventions—report of a workshop , 1998, Movement disorders : official journal of the Movement Disorder Society.

[10]  M. Beal,et al.  Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury , 1996, Nature Genetics.

[11]  Pamela L. Follett,et al.  Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  U. Müller,et al.  Differential regulation of toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice , 2009, Neuroscience Letters.

[13]  S. Miller,et al.  Differential activation of astrocytes by innate and adaptive immune stimuli , 2005, Glia.

[14]  F. Crews,et al.  Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration , 2007, Glia.

[15]  D. Davies,et al.  Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA , 2008, Science.

[16]  S. Akira,et al.  Macrophages and Myeloid Dendritic Cells, but Not Plasmacytoid Dendritic Cells, Produce IL-10 in Response to MyD88- and TRIF-Dependent TLR Signals, and TLR-Independent Signals1 , 2006, The Journal of Immunology.

[17]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[18]  Gerd Kempermann,et al.  Adult neurogenesis and repair of the adult CNS with neural progenitors, precursors, and stem cells , 2005, Progress in Neurobiology.

[19]  Shijie Jin,et al.  Tumor Necrosis Factor-α Induces Neurotoxicity via Glutamate Release from Hemichannels of Activated Microglia in an Autocrine Manner* , 2006, Journal of Biological Chemistry.

[20]  I. Bechmann,et al.  IDO (indolamine 2,3-dioxygenase) expression and function in the CNS. , 2003, Advances in experimental medicine and biology.

[21]  W. Schulz-Schaeffer,et al.  Screening of innate immune receptors in neurodegenerative diseases: A similar pattern , 2009, Neurobiology of Aging.

[22]  F. Mégret,et al.  Monique Lafon Producers of Beta Interferon Human Neurons to Become Strong Virus Infection Switches Tlr-3-positive , 2005 .

[23]  C. Iadecola,et al.  MyD88-5 links mitochondria, microtubules, and JNK3 in neurons and regulates neuronal survival , 2007, The Journal of experimental medicine.

[24]  M. Mattson,et al.  Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits , 2007, Proceedings of the National Academy of Sciences.

[25]  M. Block,et al.  Microglia-mediated neurotoxicity: uncovering the molecular mechanisms , 2007, Nature Reviews Neuroscience.

[26]  Guy C. Brown,et al.  Inflammatory Neurodegeneration Mediated by Nitric Oxide from Activated Glia-Inhibiting Neuronal Respiration, Causing Glutamate Release and Excitotoxicity , 2001, The Journal of Neuroscience.

[27]  S. Yang,et al.  Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide. , 2000, The Journal of pharmacology and experimental therapeutics.

[28]  S. Mckercher,et al.  Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis , 2006, Proceedings of the National Academy of Sciences.

[29]  S. Akira,et al.  The role of Toll-like receptors in immune disorders , 2006, Expert opinion on biological therapy.

[30]  C. Lomen‐Hoerth,et al.  Amyotrophic Lateral Sclerosis from Bench to Bedside , 2008, Seminars in neurology.

[31]  M. Netea,et al.  Functional Consequences of Toll-like Receptor 4 Polymorphisms , 2008, Molecular medicine.

[32]  Yaniv Ziv,et al.  Toll-like receptors modulate adult hippocampal neurogenesis , 2007, Nature Cell Biology.

[33]  L. Lue,et al.  Microglial chemotaxis, activation, and phagocytosis of amyloid β-peptide as linked phenomena in Alzheimer's disease , 2001, Neurochemistry International.

[34]  S. Rivest,et al.  Toll‐like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram‐negative bacterial cell wall components , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  Richard Mayeux,et al.  Epidemiology of neurodegeneration. , 2003, Annual review of neuroscience.

[36]  R. Sidman,et al.  Toll-Like Receptor 3 Is a Potent Negative Regulator of Axonal Growth in Mammals , 2007, The Journal of Neuroscience.

[37]  W. Gong,et al.  CpG‐containing oligodeoxynucleotide promotes microglial cell uptake of amyloid β 1–42 peptide by up‐regulating the expression of the G‐protein‐coupled receptor mFPR2 , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  A. Aguzzi,et al.  The prion's elusive reason for being. , 2008, Annual review of neuroscience.

[39]  K. L. Richard,et al.  Toll-Like Receptor 2 Acts as a Natural Innate Immune Receptor to Clear Amyloid β1–42 and Delay the Cognitive Decline in a Mouse Model of Alzheimer's Disease , 2008, The Journal of Neuroscience.

[40]  B. Liu,et al.  The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery , 2008, Fundamental & clinical pharmacology.

[41]  J. Deisenhofer,et al.  A structural basis of the interactions between leucine-rich repeats and protein ligands , 1995, Nature.

[42]  B. Thomas Parkinson's disease: from molecular pathways in disease to therapeutic approaches. , 2009, Antioxidants & redox signaling.

[43]  K. Ishii,et al.  The LPS receptor (CD14) links innate immunity with Alzheimer's disease , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  S. Paik,et al.  Crystal Structure of the TLR1-TLR2 Heterodimer Induced by Binding of a Tri-Acylated Lipopeptide , 2007, Cell.

[45]  H. Hagberg,et al.  The role of Toll-like receptors in perinatal brain injury. , 2009, Clinics in perinatology.

[46]  G. Bing,et al.  Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration , 2003, Neurobiology of Disease.

[47]  Soo Young Park,et al.  Gangliosides trigger inflammatory responses via TLR4 in brain glia. , 2006, The American journal of pathology.

[48]  Adriano Aguzzi,et al.  Pathogenesis of prion diseases: current status and future outlook , 2006, Nature Reviews Microbiology.

[49]  R. Sidman,et al.  TLR8: An Innate Immune Receptor in Brain, Neurons and Axons , 2007, Cell cycle.

[50]  L. Tong,et al.  Structural basis for signal transduction by the Toll/interleukin-1 receptor domains , 2000, Nature.

[51]  M. Gurney,et al.  Mutant CuZn superoxide dismutase in motor neuron disease , 1998, Journal of Inherited Metabolic Disease.

[52]  S. Miller,et al.  Innate and adaptive immune responses of the central nervous system. , 2006, Critical reviews in immunology.

[53]  J. Julien,et al.  Exacerbation of Motor Neuron Disease by Chronic Stimulation of Innate Immunity in a Mouse Model of Amyotrophic Lateral Sclerosis , 2004, The Journal of Neuroscience.

[54]  R. Nitsch,et al.  A Vicious Cycle Involving Release of Heat Shock Protein 60 from Injured Cells and Activation of Toll-Like Receptor 4 Mediates Neurodegeneration in the CNS , 2008, The Journal of Neuroscience.

[55]  E. Dagand,et al.  TLR2 Mediates Neuroinflammation and Neuronal Damage1 , 2007, The Journal of Immunology.

[56]  G. Nicolardi,et al.  Expression of TLR4 and CD14 in the central nervous system (CNS) in a MPTP mouse model of Parkinson's-like disease. , 2008, Immunopharmacology and immunotoxicology.

[57]  R. Paczynski,et al.  Treating brain swelling , 1996, Neurology.

[58]  M. Arditi,et al.  Cooperation of Toll-Like Receptor 2 and 6 for Cellular Activation by Soluble Tuberculosis Factor and Borrelia burgdorferi Outer Surface Protein A Lipoprotein: Role of Toll-Interacting Protein and IL-1 Receptor Signaling Molecules in Toll-Like Receptor 2 Signaling1 , 2001, The Journal of Immunology.

[59]  J. Cano,et al.  Lipopolysaccharide Intranigral Injection Induces Inflammatory Reaction and Damage in Nigrostriatal Dopaminergic System , 1998, Journal of neurochemistry.

[60]  K. Abel,et al.  Immune defects in Alzheimer's disease: new medications development , 2008, BMC Neuroscience.

[61]  A. Davies,et al.  Bacterial lipopolysaccharide regulates nociceptin expression in sensory neurons , 2008, Journal of neuroscience research.

[62]  Ling Li,et al.  Role of toll-like receptor signalling in Abeta uptake and clearance. , 2006, Brain : a journal of neurology.

[63]  M. Mattson,et al.  Toll-Like Receptor 3 Is a Negative Regulator of Embryonic Neural Progenitor Cell Proliferation , 2008, The Journal of Neuroscience.

[64]  I. Bertini,et al.  Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: A possible general mechanism for familial ALS , 2007, Proceedings of the National Academy of Sciences.

[65]  J. Tavernier,et al.  TLR-4, IL-1R and TNF-R signaling to NF-κB: variations on a common theme , 2008, Cellular and Molecular Life Sciences.

[66]  J. Wiltfang,et al.  Amyloid beta peptide 1–40 enhances the action of Toll‐like receptor‐2 and ‐4 agonists but antagonizes Toll‐like receptor‐9‐induced inflammation in primary mouse microglial cell cultures , 2005, Journal of neurochemistry.

[67]  Douglas R. McDonald,et al.  A Cell Surface Receptor Complex for Fibrillar β-Amyloid Mediates Microglial Activation , 2003, The Journal of Neuroscience.

[68]  T. Kielian,et al.  The role of Toll‐like receptors in CNS response to microbial challenge , 2006, Journal of neurochemistry.

[69]  R. Sidman,et al.  Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis , 2006, The Journal of cell biology.

[70]  D. Feinstein,et al.  The Clinical Course of Experimental Autoimmune Encephalomyelitis is Associated with a Profound and Sustained Transcriptional Activation of the Genes Encoding Toll‐like Receptor 2 and CD14 in the Mouse CNS , 2002, Brain pathology.

[71]  S. Akira,et al.  Prion pathogenesis in the absence of Toll‐like receptor signalling , 2003, EMBO reports.

[72]  F. Mégret,et al.  The innate immune facet of brain , 2007, Journal of Molecular Neuroscience.

[73]  D. Wilcock,et al.  Intrahippocampal LPS injections reduce Aβ load in APP+PS1 transgenic mice , 2001, Neurobiology of Aging.

[74]  L. Adorini,et al.  Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. , 1998, Journal of immunology.

[75]  W. Brück,et al.  Differential regulation of myelin phagocytosis by macrophages/microglia, involvement of target myelin, Fc receptors and activation by intravenous immunoglobulins , 2002, Journal of neuroscience research.

[76]  K. Fassbender,et al.  Innate immune receptor expression in normal brain aging , 2007, Neuroscience.

[77]  土井 由紀子 Microglia activated with Toll-like receptor 9 ligand CpG attenuate oligomeric amyloid β neurotoxicity in vitro and in vivo models of Alzheimer's disease , 2009 .

[78]  J. Julien,et al.  Extracellular mutant SOD1 induces microglial‐mediated motoneuron injury , 2010, Glia.

[79]  Hayyoung Lee,et al.  The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex , 2009, Nature.

[80]  N. Gay,et al.  Drosophila Toll and IL-1 receptor , 1991, Nature.

[81]  C. Gazzaruso,et al.  Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease , 2006, Neuroscience Letters.

[82]  J. Antel,et al.  TLR Signaling Tailors Innate Immune Responses in Human Microglia and Astrocytes1 , 2005, The Journal of Immunology.

[83]  D. Cleveland,et al.  Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease , 2007, Nature Neuroscience.

[84]  R. Coffman,et al.  Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists , 2007, Nature Medicine.

[85]  T. Morgan,et al.  Peroxynitrite Mediates Neurotoxicity of Amyloid β-Peptide1–42- and Lipopolysaccharide-Activated Microglia , 2002, The Journal of Neuroscience.

[86]  S. McBride Prion protein: a pattern recognition receptor for viral components and uric acid responsible for the induction of innate and adaptive immunity. , 2005, Medical hypotheses.

[87]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[88]  G. Landreth,et al.  CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation , 2009, The Journal of Neuroscience.

[89]  Jie-Oh Lee,et al.  Structures of the toll-like receptor family and its ligand complexes. , 2008, Immunity.

[90]  A. Aderem,et al.  The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[91]  G. Hardiman,et al.  A family of human receptors structurally related to Drosophila Toll. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[92]  Patrick Couvreur,et al.  Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis , 2000, The Journal of pathology.

[93]  H. Braak,et al.  Staging of Alzheimer-related cortical destruction. , 1997, International psychogeriatrics.

[94]  J. Edwardson,et al.  Chronic glial activation, neurodegeneration, and APP immunoreactive deposits following acute administration of double‐stranded RNA , 2003, Glia.

[95]  P. Scumpia,et al.  Double‐stranded RNA signals antiviral and inflammatory programs and dysfunctional glutamate transport in TLR3‐expressing astrocytes , 2005, Glia.

[96]  C. Janeway,et al.  The immune system evolved to discriminate infectious nonself from noninfectious self. , 1992, Immunology today.

[97]  I. Bechmann,et al.  A Mechanism for Neurodegeneration Induced by Group B Streptococci through Activation of the TLR2/MyD88 Pathway in Microglia1 , 2006, The Journal of Immunology.

[98]  Adriano Aguzzi,et al.  Molecular mechanisms of prion pathogenesis. , 2008, Annual review of pathology.

[99]  R. Crowther,et al.  α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .

[100]  S. Akira,et al.  A Critical Role of Toll-like Receptor 2 in Nerve Injury-induced Spinal Cord Glial Cell Activation and Pain Hypersensitivity* , 2007, Journal of Biological Chemistry.

[101]  T. Wisniewski,et al.  Accelerated Prion Disease Pathogenesis in Toll-Like Receptor 4 Signaling-Mutant Mice , 2008, Journal of Virology.

[102]  R. Ravid,et al.  Toll‐like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators , 2006, Glia.

[103]  A. Bowie,et al.  The human adaptor SARM negatively regulates adaptor protein TRIF–dependent Toll-like receptor signaling , 2006, Nature Immunology.

[104]  C. Caruso,et al.  TLR4 Polymorphisms and Ageing: Implications for the Pathophysiology of Age-Related Diseases , 2009, Journal of Clinical Immunology.

[105]  S. Rivest,et al.  Circulating cell wall components derived from gram‐negative, not gram‐positive, bacteria cause a profound induction of the gene‐encoding Toll‐like receptor 2 in the CNS , 2001, Journal of neurochemistry.

[106]  D. Farfara,et al.  Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease , 2008, Journal of cellular and molecular medicine.

[107]  H. Soininen,et al.  Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in alzheimer's disease , 1995, Neuroscience.

[108]  J. Fazakerley,et al.  In response to pathogens, glial cells dynamically and differentially regulate Toll-like receptor gene expression , 2005, Journal of Neuroimmunology.

[109]  H. Weiner,et al.  A nasal proteosome adjuvant activates microglia and prevents amyloid deposition , 2008, Annals of neurology.

[110]  Makoto Hashimoto,et al.  Effects of α-Synuclein Immunization in a Mouse Model of Parkinson’s Disease , 2005, Neuron.

[111]  J. Rossiter,et al.  Expression of Toll-like receptor 3 in the human cerebellar cortex in rabies, herpes simplex encephalitis, and other neurological diseases , 2006, Journal of NeuroVirology.

[112]  S. Miller,et al.  Microglia Initiate Central Nervous System Innate and Adaptive Immune Responses through Multiple TLRs1 , 2004, The Journal of Immunology.

[113]  U. Heinemann,et al.  Interleukin 4 and interleukin 10 levels are elevated in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. , 2005, Archives of neurology.

[114]  N. Johnson,et al.  Viruses selectively upregulate Toll-like receptors in the central nervous system. , 2005, Biochemical and biophysical research communications.

[115]  Pamela L. Follett,et al.  The Toll-Like Receptor TLR4 Is Necessary for Lipopolysaccharide-Induced Oligodendrocyte Injury in the CNS , 2002, The Journal of Neuroscience.

[116]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[117]  P. Dobrzanski,et al.  Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease , 1998, Brain Research.

[118]  J. Ringman,et al.  Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin , 2007, Proceedings of the National Academy of Sciences.

[119]  D. Davies,et al.  The TLR3 signaling complex forms by cooperative receptor dimerization , 2008, Proceedings of the National Academy of Sciences.

[120]  A. Aderem,et al.  Cutting Edge: Functional Interactions Between Toll-Like Receptor (TLR) 2 and TLR1 or TLR6 in Response to Phenol-Soluble Modulin1 , 2001, The Journal of Immunology.

[121]  A. Bailey,et al.  Who Is at Risk and Why? Teachers' Reasons for Concern and Their Understanding and Assessment of Early Literacy , 2006 .

[122]  S. Lockett,et al.  Activation of Toll-like Receptor 2 on Microglia Promotes Cell Uptake of Alzheimer Disease-associated Amyloid β Peptide* , 2006, Journal of Biological Chemistry.

[123]  R. Ravid,et al.  Identification of soluble CD14 as an endogenous agonist for Toll‐like receptor 2 on human astrocytes by genome‐scale functional screening of glial cell derived proteins , 2007, Glia.

[124]  Sumana Chakravarty,et al.  Toll-Like Receptor 4 on Nonhematopoietic Cells Sustains CNS Inflammation during Endotoxemia, Independent of Systemic Cytokines , 2005, The Journal of Neuroscience.

[125]  H. Kretzschmar,et al.  Postexposure prophylaxis against prion disease with a stimulator of innate immunity , 2002, The Lancet.